Absorption and distribution of sodium [2-14C]barbital in tissues of normal and dystrophic mice.
The absorption and distribution of [2-14C]barbital after oral administration was studied in various tissues, including skeletal muscle, of normal and dystrophic mice. There appeared to be a more rapid gastric emptying in the mutant homozygote as reflected in lower levels of the drug recuperated from the gastrointestinal tract. This resulted in initially higher plasma and tissue concentrations of barbital in the dystrophic mice. Two hours after oral administration, this kinetic profile was reversed so that less barbital remained in the tissues of the dystrophic mouse. The tissue:plasma concentration ratios were consistently, but not significantly, higher in all tissues of the dystrophic animals. Analysis of the half-life of the drug in both groups suggests that there is an increase in the distribution volume of barbital in the dystrophic mice. The phenomenon of more rapid absorption of the barbiturate seems to be more consistent as the symptoms of the disease progress. The altered absorption and disposition of barbital in various tissues of the dystrophic mouse support the concept that a generalized multisystemic disorder may be crucial to the pathogenesis of murine muscular dystrophy, in contradistinction to a purely myogenic origin.
D000818:Animals; D001462:Barbital / Q000378:metabolism*; D001463:Barbiturates / Q000378:metabolism*; D007408:Intestinal Absorption; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009136:Muscular Dystrophies / Q000378:metabolism*; D013997:Time Factors; D014018:Tissue Distribution
D001463:Barbiturates; D001462:Barbital